Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
23%
upside
6 price targets
|
0
%
|
|
|
|
23%
upside
5 price targets
|
0
%
|
|
|
|
23%
upside
6 price targets
|
0
%
|
|
|
704
Royalty Pharma
RPRX
$16.4B
|
23%
upside
3 price targets
|
0
%
|
|
|
23%
upside
15 price targets
|
0
%
|
|
|
|
23%
upside
3 price targets
|
0
%
|
|
|
|
22%
upside
5 price targets
|
0
%
|
|
|
|
22%
upside
7 price targets
|
0
%
|
|
|
|
22%
upside
4 price targets
|
0
%
|
|
|
|
22%
upside
8 price targets
|
0
%
|
|
|
711
AutoNation
AN
$7.49B
|
22%
upside
6 price targets
|
0
%
|
|
|
22%
upside
13 price targets
|
0
%
|
|
|
|
22%
upside
11 price targets
|
0
%
|
|
|
|
22%
upside
4 price targets
|
0
%
|
|
|
|
22%
upside
7 price targets
|
0
%
|
|
|
|
22%
upside
10 price targets
|
0
%
|
|
|
|
22%
upside
15 price targets
|
0
%
|
|
|
|
22%
upside
3 price targets
|
0
%
|
|
|
|
22%
upside
6 price targets
|
0
%
|
|
|
|
22%
upside
3 price targets
|
0
%
|
|
|
|
22%
upside
8 price targets
|
0
%
|
|
|
|
22%
upside
9 price targets
|
0
%
|
|
|
|
22%
upside
7 price targets
|
0
%
|
|
|
|
22%
upside
5 price targets
|
0
%
|
|
|
|
22%
upside
4 price targets
|
0
%
|
|